Related Experiment Video
Updated: Nov 8, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease
Masaki Ikeda1,2,3, Sayaka Kodaira4, Hiroo Kasahara1
1Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Abstract:
Lobar cerebral microbleeds (CMBs) in Alzheimer's disease (AD) are associated with cerebral amyloid angiopathy (CAA) due to vascular amyloid beta (Aβ) deposits. However, the relationship between lobar CMBs and clinical subtypes of AD remains unknown. Here, we enrolled patients with early- and late-onset amnestic dominant AD, logopenic variant of primary progressive aphasia (lvPPA) and posterior cortical atrophy (PCA) who were compatible with the AD criteria. We then examined the levels of cerebrospinal fluid (CSF) biomarkers [Aβ1-42, Aβ1-40, Aβ1-38, phosphorylated tau 181 (P-Tau), total tau (T-Tau), neurofilament light chain (NFL), and chitinase 3-like 1 protein (YKL-40)], analyzed the number and localization of CMBs, and measured the cerebral blood flow (CBF) volume by 99mTc-ethyl cysteinate dimer single photon emission computerized tomography (99mTc ECD-SPECT), as well as the mean cortical standard uptake value ratio by 11C-labeled Pittsburgh Compound B-positron emission tomography (11C PiB-PET). Lobar CMBs in lvPPA were distributed in the temporal, frontal, and parietal lobes with the left side predominance, while the CBF volume in lvPPA significantly decreased in the left temporal area, where the number of lobar CMBs and the CBF volumes showed a significant inversely correlation. The CSF levels of NFL in lvPPA were significantly higher compared to the other AD subtypes and non-demented subjects. The numbers of lobar CMBs significantly increased the CSF levels of NFL in the total AD patients, additionally, among AD subtypes, the CSF levels of NFL in lvPPA predominantly were higher by increasing number of lobar CMBs. On the other hand, the CSF levels of Aβ1-38, Aβ1-40, Aβ1-42, P-Tau, and T-Tau were lower by increasing number of lobar CMBs in the total AD patients. These findings may suggest that aberrant brain hypoperfusion in lvPPA was derived from the brain atrophy due to neurodegeneration, and possibly may involve the aberrant microcirculation causing by lobar CMBs and cerebrovascular injuries, with the left side dominance, consequently leading to a clinical phenotype of logopenic variant.
Insights
Lobar cerebral microbleeds (CMBs) in Alzheimer's disease (AD) are linked to neurodegeneration, particularly in logopenic variant PPA (lvPPA). Increased CMBs correlate with higher neurofilament light chain (NFL) levels, suggesting microvascular injury contributes to lvPPA.
Area of Science:
- Neurology
- Neuroimaging
- Biomarker Research
Background:
- Lobar cerebral microbleeds (CMBs) are associated with cerebral amyloid angiopathy (CAA) in Alzheimer's disease (AD).
- The specific relationship between lobar CMBs and distinct AD clinical subtypes remains unclear.
- Understanding these associations is crucial for diagnosing and managing AD variants.
Purpose of the Study:
- To investigate the association between lobar CMBs and clinicopathological features across different AD subtypes.
- To explore the correlation of CMBs with cerebrospinal fluid (CSF) biomarkers and cerebral blood flow (CBF).
- To elucidate the role of CMBs in the neurodegenerative processes underlying specific AD phenotypes.
Main Methods:
- Recruited patients with early/late-onset amnestic AD, logopenic variant PPA (lvPPA), and posterior cortical atrophy (PCA).
- Assessed CSF biomarkers (Aβ, tau, NFL, YKL-40), CMBs, CBF (99mTc ECD-SPECT), and amyloid burden (11C PiB-PET).
- Analyzed correlations between CMB load, biomarker levels, and CBF across AD subtypes.
Main Results:
- Lobar CMBs in lvPPA predominantly occurred in the left temporal lobe, correlating inversely with CBF in that region.
- CSF NFL levels were significantly higher in lvPPA and increased with CMB load across all AD patients.
- CSF Aβ and tau levels decreased with increasing CMB load in AD patients.
Conclusions:
- Aberrant brain hypoperfusion in lvPPA may stem from neurodegeneration and microcirculatory dysfunction linked to CMBs.
- Left-sided CMBs and associated cerebrovascular injury might contribute to the lvPPA phenotype.
- CMBs are associated with distinct biomarker profiles and neuroimaging findings in AD subtypes, particularly lvPPA.
More Related Videos
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
06:39Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
Published on: October 17, 2018
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....